Report Overview

According to the deep-dive market assessment study by Growth Plus Reports, the global E. coli testing market was valued at US$ 1.72 billion in 2022 and is expected to register a revenue CAGR of 7.65% to reach US$ 3.34 billion by 2031.

E. Coli Testing Market Fundamentals                                                                  

Escherichia coli (E. coli) are rod-shaped gram-negative bacteria found in the guts of humans and animals. Some E. coli strains are essential to a healthy human intestinal system, and most E. coli strains are usually harmless. However, some strains of E. coli, such as Shiga toxin-producing E. coli, can cause severe foodborne illness and are mostly transmitted through the consumption of undercooked or raw ground meat products, contaminated raw vegetables, raw milk, and sprouts. There are various pathogenic E. coli strains that are classified based on their pathotypes. There are six pathotypes of E. coli that are associated with diarrhea and are known as diarrheagenic E. coli. The process of detecting and monitoring the presence of foodborne pathogens is referred to as E. coli testing. E. coli infection can cause numerous illnesses, such as food poisoning, pneumonia, and urinary tract infections (UTIs). According to a study published in the journal Emerging Infectious Diseases, E. coli is responsible for 80%-85% of all urinary tract infections.

E. Coli Testing Market Dynamics

The rising incidence of E. coli infections in developed and developing countries is a major driver for the E. coli testing market. For instance, according to NIH 2022 report, UTIs continue to impact around 150 million individuals globally yearly, causing significant morbidity and expensive medical expenditures. UTIs were responsible for approximately 10 million office visits, over 2 million emergency room visits, and 100,000 hospitalizations annually in the United States. Outbreaks of foodborne illnesses, contaminated water supplies, and healthcare-associated infections contribute to the demand for effective E. coli testing solutions. Increasing awareness among consumers about foodborne illnesses, including those caused by E. coli, has led to a higher demand for safe food products. This awareness has driven the need for comprehensive testing along the entire food supply chain to identify and prevent E. coli contamination, ensuring consumer safety. The development of innovative testing technologies and methods has significantly improved the accuracy, speed, and sensitivity of E. coli testing. For instance, in June 2022, researchers from the Indian Institute of Technology (IIT) Kanpur developed a highly sensitive enzyme-substrate medium-based E. coli water testing kit that can detect the presence or absence of even a single E. coli in drinking water. 

Molecular diagnostics, such as polymerase chain reaction (PCR) and nucleic acid amplification techniques, have revolutionized E. coli testing by providing rapid and precise results. These advancements have increased the adoption of E. coli testing solutions in various sectors, including food safety and clinical diagnostics. With the globalization of the food trade, the demand for E. coli testing has risen. Importing and exporting countries require robust testing protocols to ensure the safety of food products, especially perishable items like fresh produce and meat. Additionally, point-of-care testing for E. coli, such as rapid diagnostic tests and portable devices, is gaining prominence. These tests provide quick results at the site of care, enabling immediate diagnosis and treatment decisions. The convenience and speed of point-of-care testing are particularly beneficial in resource-limited settings and during outbreaks, driving the demand for such testing solutions. E. coli is a common indicator of water contamination, and ensuring safe water supplies is a global priority. Monitoring and testing water sources for E. coli contamination are critical to prevent waterborne diseases. Increasing efforts to improve water quality, especially in developing countries, contribute to the demand for E. coli testing solutions in the water treatment and monitoring sector. 

However, identifying and differentiating specific pathogenic strains, such as Shiga toxin-producing E. coli (STEC) or enteropathogenic E. coli (EPEC), can be challenging. Accurate and specific detection methods must be developed to distinguish between different E. coli strains and determine their virulence potential. Implementing comprehensive E. coli testing protocols can be costly, especially for large-scale food or water treatment facility operations. The expenses associated with purchasing testing equipment, reagents, and maintaining skilled personnel can be a significant barrier, particularly for small businesses or resource-limited settings. Performing E. coli testing requires trained personnel with expertise in microbiological techniques and handling potentially hazardous microorganisms. The availability of skilled personnel and specialized laboratories can be limited, particularly in rural or remote areas, which may hinder the widespread adoption of E. coli testing. Moreover, E. coli testing methods may sometimes produce false-negative or false-positive results. False negatives can lead to releasing contaminated food products or water supplies, posing risks to public health. Ensuring the accuracy and reliability of testing methods is critical to address this challenge. Compliance with regulatory standards and guidelines for E. coli testing can be complex and demanding. 

E. Coli Testing Market Ecosystem

The global E. coli testing market has been analyzed from the following perspectives: by testing method, end user, and region. 

E. Coli Testing Market by Testing Method

Based on the testing methods, the global E. coli testing market is segmented into environmental testing and clinical testing. 

The environment testing method segment accounts for a prominent amount of revenue shares in the global market, owing to factors such as the need for less skill and equipment and the ability to assess large sample sizes, such as water bodies. Various environmental samples are tested regularly to detect E. coli contamination and take preventive measures, particularly during epidemics, to halt the spread of infections. The rise in water and foodborne diseases has increased global demand for E. coli testing. During disease outbreaks, the World Health Organization (WHO) encourages national strategies and initiatives in developing countries to promote the management of diarrhea and its complications and improve access to safe drinking water and sanitation. Water test kits are useful in rural areas, where the regions may lack laboratory equipment for water quality monitoring.

E. Coli Testing Market by End User

Based on the end user, the global E. coli testing market is segmented into water and wastewater, treatment plants, government agencies, hospitals and clinics, diagnostic laboratories, and others.

Diagnostic laboratories account for a sizeable revenue share in the global market. Diagnostic laboratories offer E. coli testing services to various industries, including food, water treatment facilities, healthcare settings, and research institutions. Diagnostic laboratories provide reliable and accurate E. coli testing results. They employ standardized protocols and quality control measures to ensure the integrity and accuracy of test outcomes. Diagnostic laboratories follow regulatory guidelines and participate in proficiency testing programs to maintain the highest testing quality standards. Their expertise in handling and processing samples helps minimize the risk of false negatives or false positives in E. coli testing. Molecular diagnostic techniques, such as polymerase chain reaction (PCR) and next-generation sequencing (NGS), have revolutionized E. coli testing by enabling rapid and specific identification of E. coli strains and their virulence factors. Diagnostic laboratories have a team of experienced scientists and technicians who specialize in microbiology and infectious diseases. They offer expert advice and consultation to clients regarding E. coli testing, interpretation of test results, and recommendations for control and prevention measures. Many diagnostic laboratories engage in research and development activities to advance the field of E. coli testing. They contribute to the development of new testing methodologies, evaluate the performance of emerging technologies, and participate in the validation of novel diagnostic assays. The research conducted by diagnostic laboratories helps improve the accuracy, sensitivity, and efficiency of E. coli testing, driving advancements in the field.

E. Coli Testing Market by Region

Based on the region, the global E. coli testing market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

North America accounts for a significant revenue share in the global market. North America has stringent food safety regulations in place to ensure the prevention and control of foodborne illnesses, including those caused by E. coli contamination. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the Canadian Food Inspection Agency (CFIA) have established comprehensive guidelines and standards for E. coli testing in food products. Compliance with these regulations drives the region's demand for E. coli testing solutions. North America has experienced several high-profile E. coli outbreaks in recent years, which have heightened awareness about the importance of E. coli testing. These outbreaks have occurred in various sectors, including the food industry, water supplies, and healthcare settings. The need to prevent and control E. coli contamination has led to increased demand for testing services and technologies in North America. Additionally, this region also boasts advanced healthcare infrastructure, including well-equipped diagnostic laboratories and research institutions. The region has a strong network of clinical and reference laboratories that offer E. coli testing services to healthcare providers, facilitating early diagnosis and treatment of E. coli infections. 

North America is at the forefront of technological advancements in the field of diagnostics, including E. coli testing. The region has developed and adopted advanced testing technologies such as molecular diagnostics, rapid diagnostic tests, and automated platforms. These technological advancements improve the speed, accuracy, and efficiency of E. coli testing, driving market growth in North America. For instance, in June 2021, Bio-Rad Laboratories, based in the U.S., announced the approval of its RAPID’E coli 2 Agar for water testing by the Environmental Protection Agency (EPA) for testing intended for E. coli and total coliforms in drinking and untreated water. North America places a strong emphasis on food safety and has robust systems in place to ensure the quality and safety of food products. The region's commitment to maintaining high food safety standards and protecting public health creates a significant demand for E. coli testing solutions. Food manufacturers, processors, and regulatory bodies in North America prioritize rigorous testing protocols to prevent E. coli contamination. North America is a hub for research and development activities in the field of diagnostics, including E. coli testing. Academic institutions, research organizations, and pharmaceutical companies in the region invest in research to develop new testing methodologies, enhance existing technologies, and validate diagnostic assays. The presence of a vibrant research and development ecosystem contributes to the dominance of North America in the market.

E. Coli Testing Market Competitive Landscape

The prominent players operating in the global E. coli testing market are:

• Becton, Dickinson and Company
• Meridian Bioscience Inc.
• IDEXX Laboratories Inc.
• CPI International Inc.
• Pro-Lab Diagnostics Inc.
• Thermo Fisher Scientific Inc. 
• Bio-Rad Laboratories Inc.
• BioMerieux Inc.
• Abbott Laboratories Inc. (Alere Inc.)
• NanoLogix Inc.

Strategic Developments

• In February 2023, Microba Life Sciences Limited, a precision microbiome firm, launched its next-generation testing product line, MetaXplore, which has been introduced to Australian healthcare practitioners under a new brand, Co-Biome.
• In November 2022, IDEXX, a global pioneer in rapid microbiology testing for water, acquired Tecta-PDS. This forward-thinking Canadian firm has automated water microbiology testing for parameters such as E. coli and total coliforms. The investment enables IDEXX to broaden its water microbiological testing options for both laboratory and in-field testing.

Frequently Asked Questions About This Report